Article
Labeling of a mutant estrogen receptor with an Affimer in a breast cancer cell line.
Biophysical journal - 4 Oct 2022
Ren Pin, Tiede Christian, Fanning Sean W, Adams Thomas, Speirs Valerie, Nelson Erik R, Cheng Changfeng, Moore Terry W, Greene Geoffrey L, Tomlinson Darren, Selvin Paul R
Abstract excerpt
Mutations of the intracellular estrogen receptor alpha (ERα) is implicated in 70% of breast cancers. Therefore, it is of considerable interest to image various mutants (L536S, Y537S, D538G) in living cancer cell lines, particularly as a function of various anticancer drugs. We therefore developed a small (13 kDa) Affimer, which, after fluorescent labeling, is able to efficiently label ERα by traveling through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
